title: Antibiotic resistance: a view from the pharmaceutical industry.
abstract: The development of new antibiotics has been successful in significantly reducing morbidity and mortality. With increasing use there has occurred an increase in antibiotic resistance but not a parallel increase in new agents with significantly improved spectrum of activity. Without concerted action from the pharmaceutical industry, physicians, academia, health care providers, and governments, the prospects look gloomy.
authors.affiliation: Department of Clinical Research and Development, SmithKline Beecham Pharmaceuticals, Harlow, Essex, England.
authors.forename: R P
authors.initials: RP
authors.lastname: Bax
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004345:Drug Industry / Q000639:trends*; D004352:Drug Resistance, Microbial; D005544:Forecasting; D014943:Global Health; D010601:Pharmacology, Clinical / Q000639:trends*
chemical_list: D000900:Anti-Bacterial Agents